Literature DB >> 4072568

Long-term results in preventive medicine for type II diabetes.

M Morsiani, P Beretta, P L Pareschi, D Manservigi, L Bottoni.   

Abstract

The authors report the results of a 12-year screening for type II diabetes in their Health District (Emilia-Romagna, Northern Italy). The method consisted of two steps, following Pavel and Sdrobici, for early diagnosis of clinical diabetes and IGT. The authors found 1.03% of clinical diabetes and 2.65% of IGT cases in the population examined (200,000 subjects). Statistically significant correlations existed with regard to the various risk factors (familiarity, obesity, fetal macrosomia, occupation). Follow-up after 6 years for IGT subjects showed a 25.5% return to normal of OGTT values, 21.7% improvement, 19% unchanged, 33.8% deterioration. There was a correlation between these results and life-style (diet, reduction in calorie intake, weight loss). Twelve years after these screenings, a 2.7% drop in incidence was observed for type II diabetes in this Health District.

Entities:  

Mesh:

Year:  1985        PMID: 4072568     DOI: 10.1007/BF02590770

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  11 in total

1.  Aging and diabetes.

Authors:  R Andres
Journal:  Med Clin North Am       Date:  1971-07       Impact factor: 5.456

2.  Partial preservation of pancreatic beta-cell function in children with diabetes.

Authors:  R B Elliott; J R Crossley; C C Berryman; A G James
Journal:  Lancet       Date:  1981-07-04       Impact factor: 79.321

3.  [Dynamic epidemiology of diabetes mellitus (author's transl)].

Authors:  I Pavel; D Sdrobici
Journal:  Diabete Metab       Date:  1976-09

4.  Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus.

Authors:  A N Gorsuch; K M Spencer; J Lister; J M McNally; B M Dean; G F Bottazzo; A G Cudworth
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

5.  Human leukocyte interferon treatment of two children with insulin dependent diabetes.

Authors:  K H Rand; A L Rosenbloom; N K Maclaren; J H Silverstein; W J Riley; B E Butterworth; J W Yoon; A H Rubenstein; T C Merigan
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

6.  Community screening for diabetes by blood glucose measurement. Results of a five-year experience.

Authors:  S M Genuth; H B Houser; J R Carter; I Merkatz; J W Price; O P Schumacher; R G Wieland
Journal:  Diabetes       Date:  1976-12       Impact factor: 9.461

7.  Screening in diabetes mellitus: report of the Atlanta workshop.

Authors:  C A Herron
Journal:  Diabetes Care       Date:  1979 Jul-Aug       Impact factor: 19.112

8.  Immunization to prevent insulin-dependent diabetes mellitus? The economics of genetic screening and vaccination for diabetes.

Authors:  W L England; S D Roberts
Journal:  Ann Intern Med       Date:  1981-03       Impact factor: 25.391

9.  Community screening programs for diabetes?

Authors:  K M West
Journal:  Diabetes Care       Date:  1979 Jul-Aug       Impact factor: 19.112

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  3 in total

1.  Incidence and prevalence rates of diabetes mellitus in Italy from routine data: a methodological assessment.

Authors:  P Garancini; G Gallus; G Calori; F Formigaro; P Micossi
Journal:  Eur J Epidemiol       Date:  1991-01       Impact factor: 8.082

2.  A population-based prevalence survey of known diabetes mellitus in northern Italy based upon multiple independent sources of ascertainment.

Authors:  G Bruno; G Bargero; A Vuolo; E Pisu; G Pagano
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

3.  A prevalence study of known diabetes mellitus in Tuscany assessed from pharmaceutical prescriptions and other independent sources.

Authors:  G Di Cianni; L Benzi; R Giannarelli; P Orsini; G Villani; A M Ciccarone; P Cecchetti; O Fedele; R Navalesi
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.